Wallace & Graham

Winning justice on behalf of hardworking people is what Wallace & Graham’s attorneys are all about.

In the News

Judge Orders Giant Pork Producer to Clean up Water Pollution: A federal judge is telling a major pork producer to live up to an agreement it signed 11 years ago and work on cleaning up water pollution tied to almost a dozen industry-scale hog operations.

NC legislative judical NEWS UPDATES FROM WG LOGOU.S. District Court Judge Malcolm Howard Has Ordered Murphy-Brown LLC, To Fix Problems And Clean Up Water Pollution At 11 Industry-Scale Hog Operation Sites Located in Eastern North Carolina.

According to a report from US NEWS & WORLD REPORT, a North Carolina Federal Judge ruled that after years of delay Murphy-Brown LLC must have a mutually agreed consultant develop plans to fix problems at 11 sites identified in 2011. The sites, which are industry-scale hog operations are located in Bladen, Columbus, Duplin, Pitt, Sampson, and Scotland counties.

Click here to read the full story, “Judge Orders Giant Pork Producer to Clean up Water Pollution” from U.S. News & World Report.

Big Tobacco Ads Are Back, But This Time They Include The Facts

New Tobacco Ads are coming intent on exposing the truth about the lies told by Big Tobacco, keep reading to find out more.  You may have noticed the recent reappearance of cigarette advertisements from the major cigarette manufacturers, Altria, R.J. Reynolds Tobacco, Lorillard, and Phillip Morris USA popping up in print and broadcast. These ads mark another victory against the deceptive practices…

Honda issues recall that impacts 900,000, 2011 to 2017 Honda Odyssey Minivans after 46 reports of injuries

Honda has issued the recall of the Honda Odyssey Minivans models from 2011 to 2017, after 46 reports of injuries related to a problem that causes the second-row seats to fall forward. The recall will effect 900,000 Honda Odyssey Minivans, of which about 800,000 were sold in the United States.    According to a statement released by Honda if the…

FDA approves first approved adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed

On November 16, 2017, the U.S. Food and Drug Administration approved the Pfizer Inc. drug Sutent (sunitinib malate) as the first approved adjuvant treatment for adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).  An adjuvant treatment is a form of therapy that is taken by patients…

New data related to cancer deaths in the United States shows an overall drop in the numbers, but with some exceptions

The Centers for Disease Control and Prevention (CDC), the United States agency responsible for monitoring the nation’s health, along with the National Cancer Institute (NCI), the United States lead cancer research agency, have recently updated the federal statistics on cancer incidence and deaths in the US. According to that data, cancer is the second leading cause of death in the…

MEDICATIONS USED TO TREAT TYPE 2 DIABETES LINKED TO DIABETIC KETOACIDOSIS (DKA), ACUTE KIDNEY INJURIES, AND AN INCREASED RISK OF FOOT AND LEG AMPUTATION FDA HAS REVISED MEDICATION LABEL TO ADDRESS RISK

U.S._Food_and_Drug_Administration LONG LOGO

Medications used to treat type 2 diabetes Linked to diabetic ketoacidosis (DKA), acute kidney injuries, and an increased risk of foot and leg amputation

FDA HAS REVISED MEDICATION LABEL TO ADDRESS RISK

Attention: Have you or your loved ones been prescribed canagliflozin (Invokana, Invokamet) or dapagliflozin (Farxiga, Xigduo XR), a class of medications known as SGLT2 inhibitors prescription medications prescribed to control type 2 diabetes?

If so, please be advised that there have been numerous reports of patients with adverse reactions to these medications, including an increased risk for development of diabetic ketoacidosis (DKA), acute kidney injuries, and foot and leg amputation.

In response, the FDA has strengthened the existing warning about the risk related to these drugs, including revising the warnings on the drug labels to include information about acute kidney injury and added recommendations to minimize this risk. The FDA advises patients that are currently taking CANAGLIFLOZIN (INVOKANA, INVOKAMET) AND DAPAGLIFLOZIN (FARXIGA, XIGDUO XR) to speak with their healthcare provider about any concerns.

To read the FDA Safety Announcement or Report any issues follow the link below:
https://www.fda.gov/Drugs/DrugSafety/ucm557507.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

FOR MORE INFORMATION, PLEASE VISIT THE FOLLOWING LINKS:

FDA Drug Safety Communication: FDA strengthens kidney warnings for diabetes medicines CANAGLIFLOZIN (INVOKANA, INVOKAMET) AND DAPAGLIFLOZIN (FARXIGA, XIGDUO XR). https://www.fda.gov/Drugs/DrugSafety/ucm505860.htm

FDA Drug Safety Communication: Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors, https://www.fda.gov/Drugs/DrugSafety/ucm446852.htm

If you have concerns of injury as a result of taking one of these medications, including DKA, acute kidney injury, or foot and leg amputation, please call our office and ask to speak with Attorney Whitney Wallace Williams.

 

 

After OSHA Investigation and Fines for inappropriate handling of Asbestos, Davidson County Commissioners vote to take a Proactive Approach to Asbestos — by Funding an Asbestos Survey that will Include 38 County Facilities that are 35+ years old

On October 10, 2017, the Davidson County Board of Commissioners unanimously approved a proposal from TrinityEnvironmental to conduct comprehensive asbestos surveys on 38 facilities around Davidson County. The survey, costing the county $42,000, will evaluate the facilities, locate, and describe the condition of any materials that could potentially contain asbestos. The company will then advise the county and provide training…